Log In
Print this Print this

Rozerem, ramelteon (TAK-375SL)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionMelatonin MT1 and MT2 receptor agonist, sublingual formulation
Molecular Target Melatonin MT1 receptor ; Melatonin MT2 receptor
Mechanism of ActionMelatonin MT2 receptor agonist; Melatonin MT1 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationBipolar disorder
Indication DetailsTreat bipolar disorder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today